Cannabis Firm to Pay $4 Million for Stake in Vancouver Biotech

By:
Cannabis Firm to Pay $4 Million for Stake in Vancouver Biotech

Flickr / gnarburger / (CC BY 2.0)

With the federal government on the verge of legalizing marijuana, high-value strategic assets in the cannabis sector are becoming valuable.

That is how Ottawa-based cannabis firm CannaRoyalty Corp. explained its interest in buying a 20% stake in Vancouver’s Anandia Laboratories.

The companies announced January 9 that they have signed a letter of intent for CannaRoyalty (CSE:CRZ) to acquire that 20% stake in Anandia for $4 million.

Anandia is a biotechnology company that tests medical marijuana and uses genomics for plant breeding.

View Original Article Here

Repost is the designation for articles collected from the Internet whose content may interest our readers. These articles are not written by our staff and they do not necessarily reflect our views.

Related posts

Top